Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 study from AstraZeneca is evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD1043 in healthy adults living with overweig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AZD1043

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Participants, Obesity | Phase 1 | Status: RECRUITING